Pressurized Micellized Nicotine Inhaler
Solution Overview
Problem
Existing vaping devices fail to provide a safer aerosolized delivery system that can deliver a continuous amount of micellized liquid nicotine formula, leading to high nicotine inhalation levels and associated health risks.
Innovation Solution
An aerosol pressurized inhalation delivery device that eliminates the need for cartridges, heating elements, and batteries, using a metal canister pressurized with a propellant like Zephex®152a to deliver a micellized liquid nicotine formula through a continuous valve and actuator, allowing for variable nicotine dosage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional vaping devices use heating elements and batteries to vaporize nicotine solution, then nicotine delivery is achieved, but device complexity increases and reliability decreases due to electronic circuitry malfunctions and battery failure
Solution Approach 1:
The patent removes the heating element and battery from the vaping device, extracting the problematic electronic components that cause malfunctions and failures. The device replaces these with a purely mechanical actuator system that opens a valve to allow pressurized propellant and nicotine solution to be expelled, eliminating electronic circuitry entirely and thereby improving reliability while reducing complexity.
Solution Approach 2:
The patent replaces the electro-thermal vaporization system (heating element + battery) with a mechanical pressurized aerosol delivery system. The actuator mechanically opens a valve that allows propellant and nicotine solution to mix and expel as aerosol, substituting electronic/thermal mechanisms with a purely mechanical system that is more reliable and less complex.
2Object-affected harmful factors
If e-cigarette cartridges contain nicotine solution with propylene glycerin base, then nicotine delivery is achieved, but harmful factors increase due to secondhand smoke exposure and potential leaking
Solution Approach 1:
The patent changes the physical-chemical parameters of the nicotine delivery system by using a pressurized aerosol formulation with surfactants that create micelles. This allows nicotine to be delivered in a controlled aerosol state rather than as vapor from heated liquid, reducing the formation of harmful combustion byproducts and secondhand smoke while maintaining effective nicotine delivery.
Solution Approach 2:
The patent converts the potential harm of nicotine solution leaking into a benefit by using a pressurized sealed canister system with a valve mechanism. The pressurization ensures the nicotine solution remains contained until intentional actuation, and any potential leakage is prevented by the pressure differential that keeps the solution sealed until the valve is deliberately opened.
3Adaptability or versatility
If variable nicotine dosage is required, then adaptability improves, but device complexity increases due to need for precise dosage control mechanisms
Solution Approach 1:
The patent implements variable dosage capability through a dynamic actuation system where the user can press the actuator for different durations. Short presses deliver smaller amounts of aerosol while longer presses deliver larger amounts, allowing variable nicotine dosage without complex electronic controls or multiple cartridges. The simplicity of the mechanical valve system maintains low device complexity while achieving adaptability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device reduces nicotine inhalation by up to 80% while maintaining the pleasurable experience, eliminates secondhand smoke, and reduces the risk of device malfunctions and harmful exposures.
Implementation Method 1
aerosol pressurized inhalation delivery device having an actuator, continuous valve, receptacle housing and metal canister containing a micellized liquid nicotine formula and propellant such as Zephex®152a that when combined makes the micellized liquid nicotine formula and propellant homogeneous, allowing the micellized liquid nicotine formula to be expelled as an aerosol
Implementation Method 2
micellized liquid nicotine formula and propellant such as Zephex®152a that when combined makes the micellized liquid nicotine formula and propellant homogeneous
Data Source
AI summary
The present invention improves and enhances the delivery of one of an aerosolized micellized formula by use of an aerosol pressurized inhalation delivery device. The device may include one or more replaceable or reusable components, including but not limited to a canister and an actuator. Methods for using the device to deliver a continuous dosage via the delivery device are also described herein.